7 hours Wedbush Comments on Larimar Therapeutics, Inc.’s Q1 2025 Earnings (NASDAQ:LRMR) MarketBeat
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Stock analysts at Wedbush issued their Q1 2025 earnings estimates for Larimar Therapeutics in a research report issued on Thursday, October 3rd. Wedbush analyst L. Chico forecasts that the com…
Earnings · Nasdaq 100 · Science